Khoi Huynh, Ph.D.

Khoi Huynh, Ph.D., is a patent agent in the firm’s Chemical Practice group, where he focuses on preparing patent applications for domestic and international clients. He is experienced in biochemistry, organic chemistry, medicinal chemistry, organometallic chemistry, and catalysis.

Prior to joining Oblon, Dr. Huynh was a Research Scientist at a biotech start-up in Montana, where he worked on small-molecule drug discovery. He was responsible for performing computer-aided drug design using protein crystal structures, synthesizing drug candidates, and analyzing pharmacokinetic properties.

Dr. Huynh conducted research on natural product synthesis and catalytic methodology during his Ph.D. and postdoctoral training. His research included Frondosin and Liphagal total synthesis, Platinum catalysis, E3-ligase inhibition. In addition, Dr. Huynh has experience in medicinal chemistry and drug discovery, specifically structure-based drug design.

---

Education

• Montana State University (Ph.D.)
  • Chemistry
• Boston College (B.S.)
  • Biochemistry

Admissions

• Registered to practice before the U.S. Patent and Trademark Office

Technical Publications

• "Inhibitors of Cullin-RING E3 ubiquitin ligase 4 with antitumor potential", PNAS, 2021, 118(8), e2007328118
• "Inhibition and Crystal Structure of the Human DHTKD1-Thiamin Diphosphate Complex", ACS Chem. Biol. 2020, 15(8), 2041-2047
• "Platinum-Catalyzed α,β-Unsaturated Carbene Formation in the Formal Syntheses of Frondosin B and Liphagal", Org. Lett. 2017, 19, 294–297
• "Lewis Acid Mediated Vinylogous Additions of Enol Nucleophiles into an α,β-Unsaturated Platinum Carbene", Org. Lett. 2016, 18, 64−67.

Languages

• Vietnamese
• Zarma

Services

• U.S. Patent Procurement (Application Drafting & Prosecution)

Technologies

• Chemicals
• Life Sciences